Merit of ginseng in the improvement of insulin resistance

Journal of Ginseng Research

Volumn 34, Issue 3, 2010, Pages 155-159

  Cheng, Juei Tang ^a  

^a CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

Ginsenoside Rh2; Insulin resistance; Panax ginseng; Rats; Shiaw Ker

Indexed keywords

ANIMALIA; PANAX GINSENG; RATTUS;

EID: 79951777447     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2010.34.3.155     Document Type: Review

References (32)

1. Kruszynska YT, Olefsky JM. Cellular and molecular mechanisms of non-insulin dependent diabetes mellit (Pubitemid 126820690)
2. Henriksen EJ. Invited review: effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 2002;93:788-796. (Pubitemid 34810247)
3. Kennedy DO, Scholey AB. Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol Biochem Behav 2003;75:687-700. (Pubitemid 36939174)
4. Block KI, Mead MN. Immune system effects of echinacea, ginseng, and astragalus: a review. Integr Cancer Ther 2003;2:247-267. (Pubitemid 37138611)
5. Van Kampen J, Robertson H, Hagg T, Drobitch R. Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Exp Neurol 2003;184:521-529. (Pubitemid 37444059)
6. Kiefer D, Pantuso T. Panax ginseng. Am Fam Physician 2003;68:1539-1542. (Pubitemid 37296048)
7. Kimura M, Waki I, Tanaka O, Nagai Y, Shibata S. Pharmacological sequential trials for the fractionation of components with hypoglycemic activity in alloxan diabetic mice from ginseng radix. J Pharmacobiodyn 1981;4:402-409. (Pubitemid 11050223)
8. Kimura M, Suzuki J. The pattern of action of blended Chinese traditional medicines to glucose tolerance curves in genetically diabetic KK-CAy mice. J Pharmacobiodyn 1981;4:907-915. (Pubitemid 12150913)
9. Yokozawa T, Kobayashi T, Oura H, Kawashima Y. Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats. Chem Pharm Bull (Tokyo) 1985;33:869-872. (Pubitemid 15075725)
10. Kahn SE. Clinical review 135: the importance of betacell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001;86:4047-4058. (Pubitemid 32848511)
11. Kahn CR. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994;43:1066-1084. (Pubitemid 24230714)
12. Liu TP, Liu IM, Cheng JT. Improvement of insulin resistance by panax ginseng in fructose-rich chow-fed rats. Horm Metab Res 2005;37:146-151.
13. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-1693. (Pubitemid 29505408)
14. Lee KY, Park JA, Chung E, Lee YH, Kim SI, Lee SK. Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of p27kip1. Cancer Lett 1996;110:193-200. (Pubitemid 27042941)
15. Park EK, Choo MK, Kim EJ, Han MJ, Kim DH. Antiallergic activity of ginsenoside Rh2. Biol Pharm Bull 2003;26:1581-1584. (Pubitemid 41699639)
16. Lee WK, Kao ST, Liu IM, Cheng JT. Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats. Clin Exp Pharmacol Physiol 2006;33:27-32.
17. Le KA, Tappy L. Metabolic effects of fructose. Curr Opin Clin Nutr Metab Care 2006;9:469-475. (Pubitemid 44097820)
18. Chang JC, Wu MC, Liu IM, Cheng JT. Increase of insulin sensitivity by stevioside in fructose-rich chow-fed rats. Horm Metab Res 2005;37:610-616. (Pubitemid 41597571)
19. Foianini KR, Steen MS, Kinnick TR, Schmit MB, Youngblood EB, Henriksen EJ. Effects of exercise training and ACE inhibition on insulin action in rat skeletal muscle. J Appl Physiol 2000;89:687-694. (Pubitemid 30637119)
20. Henriksen EJ, Jacob S, Kinnick TR, Teachey MK, Krekler M. Selective angiotensin II receptor receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension 2001;38:884-890. (Pubitemid 34258687)
21. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002;51:1851-1858. (Pubitemid 34564298)
22. Wang L, Higashiura K, Ura N, Miura T, Shimamoto K. Chinese medicine, Jiang-Tang-Ke-Li, improves insulin resistance by modulating muscle fiber composition and muscle tumor necrosis factor-alpha in fructose-fed rats. Hypertens Res 2003;26:527-532. (Pubitemid 36974994)
23. Xie JT, Mehendale SR, Wang A, Han AH, Wu JA, Osinski J, Yuan CS. American ginseng leaf: ginsenoside analysis and hypoglycemic activity. Pharmacol Res 2004;49:113-117. (Pubitemid 37485708)
24. Cheng JT. Herbs used to treat diabetes mellitus in Chinese traditional medicine. In: Majumdar DK, Govil JN, Singh VK, editors. Recent progress in medicinal plants. Vol. 8, Phytochemistry & pharmacology II. Houston: Sci Tech Publishing, 2003. p. 175-184.
25. Lee WK, Kao ST, Liu IM, Cheng JT. Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats. Horm Metab Res 2007;39:347-354.
26. Niu CS, Yeh CH, Yeh MF, Cheng JT. Increase of adipogenesis by ginsenoside (Rh2) in 3T3-L1 cell via an activation of glucocorticoid receptor. Horm Metab Res 2009;41:271-276.
27. Park MY, Lee KS, Sung MK. Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-alpha, PPAR-gamma, and LPL RNA expressions. Life Sci 2005;77:3344-3354.
28. Su CF, Chang YY, Pai HH, Liu IM, Lo CY, Cheng JT. Infusion of beta-endorphin improves insulin resistance in fructose-fed rats. Horm Metab Res 2004;36:571-577.
29. Lai DM, Tu YK, Liu IM, Chen PF, Cheng JT. Mediation of beta-endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med 2006;72:9-13.
30. Lee KS, Yu WJ, Wang MJ, Wu HT, Chang CH, Cheng JT. Autonomic regulation of insulin secretion is changed by pentobarbital in mice. Neurosci Lett 2010;479:6-9.
31. Fisher A, Michaelson DM, Brandeis R, Haring R, Chapman S, Pittel Z. M1 muscarinic agonists as potential disease-modifying agents in Alzheimer's disease: rationale and perspectives. Ann N Y Acad Sci 2000;920:315-320. (Pubitemid 32056587)
32. Shieh PC, Tsao CW, Li JS, Wu HT, Wen YJ, Kou DH, Cheng JT. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes. Neurosci Lett 2008;434:1-5.